Hosted on MSN17d
Pancreatic cancer RNA vaccine shows durable T cell immunityIn the Phase I trial, "RNA neoantigen vaccines prime long-lived CD8 + T cells in pancreatic cancer ... T cell receptor (TCR) sequencing, and longitudinal blood and tissue analyses over a median ...
The CD8+ T cell activation involves two key interactions: The TCR/pMHCI interaction: determines antigen specificity. Promiscuity is a characteristic feature of this interaction and it is essential for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results